Notably, we outline genetic engineering modifications that significantly improve PEG3-driven transcriptional output and we show that PEG3AP1-3STA is highly active in PCa cells, including AR-independent and NEPC-like cell lines. The gene discussed is AR; the disease is posterior cortical atrophy.